Beryl Capital Management LLC Revance Therapeutics, Inc. Transaction History
Beryl Capital Management LLC
- $163 Million
- Q4 2024
A detailed history of Beryl Capital Management LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Beryl Capital Management LLC holds 5,935,009 shares of RVNC stock, worth $15.3 Million. This represents 9.37% of its overall portfolio holdings.
Number of Shares
5,935,009Holding current value
$15.3 Million% of portfolio
9.37%Shares
1 transactions
Others Institutions Holding RVNC
# of Institutions
207Shares Held
80.9MCall Options Held
2.26MPut Options Held
5.48M-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I05.1MShares$13.1 Million0.78% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY3.5MShares$8.99 Million0.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...